Clinical Trial Update: Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in the Treatment of Systemic Sclerosis [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial is evaluating Umbilical Cord Mesenchymal Stem Cells for systemic sclerosis in Phase 1/2 and is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Drugs mentioned

• Umbilical Cord Mesenchymal Stem Cells (UC-MSC) (umbilical cord mesenchymal stem cells)

Snippet

Sponsor: Shenzhen Huishan Biotechnology Co., Ltd. | Conditions: Systemic Sclerosis (SSc) | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING